GENETIC TECHNOLOGIES LIMITED — Capital/Financing Update 2003

Dec 30, 2003

Contad details for Dr. Mervyn Jacobson in USA:
Global Mobile Phone: 11-61-419-657-915
Private Fax in Colorado: +1-970-484-6698

Fax Cover Sheet

December $30^th$ 2008 Date:

Company Announcements Office, Sydney To:

From: Dr. Mervyn Jacobson, Executive Chairman, $G[T_0, |now||H]$ USA

Re: Announcement to ASX

Total Number of Pages herewith: $1+1=2$ pages total

Dear Sir/Madam,

Please find attached an Announcement, which should be released to the market at your earliest convenience.

I am currently in USA.

Please feel free to fax me to the above number, if there are any questions.

Sincerely, Dr. Mervyn Jacobson Executive Chairman

Genetic Technologies Limited • Website: www.gid.com.au • Email: info@gtg.com.au.WBN 17 009 212 328
Registered Office • 60-70 Hanover Street Fitzroy VIC 3065 Australia • Postal Address P.O. Bax 115 Fitzroy Victoria 3065 Australia Phone 61 3 9415 1136 · Fax 61 3 9417 2987 Corporate Office • Level 12. 75 Elizabeth Street Sydney NSW 2000 Australia
Phone 61 2 9233 5016 • Fax 61 2 9232 5313

$\bf{l}$

December $30^th$ , 2003

The Manager Company Announcements Office Australian Stock Exchange Limited Exchange Centre 20 Bridge Street $s_{\text{ydndy}}$ NS $\text{w}$ 2000

Dear Sir.

GTG Grants First Commercial Licenselin Canada.

Genetic Technologies Limited (G#G-ASX) is very pleased to announce it has granted a commercial license to its non-coding analysis and mapping materias to TM Bioscience Corporation (TSE-TMC), headquartered in Toronto, Canada

TM Bioscidnce is a leading provider of diagnostic kits for himan genetic resting. These kits are exported globally by TM piosciences.

The financial terms of this license are covered by confidentiality, and acceptingly, dannot be disclosed.

GTG is particularly pleased note that this is the first commet call local extented by GTG to any biotechnology company in Canada.

GTG will continue to grant licenses and to make its non-doding patents reality accessible for commercial applications and also for research applications, worldwide, Further announcements will be made as appropriate.

Yours faithfully. Dr Mervyn Jacobson Executive Chairman

Genetic Technologies Limited • Website: www.gtglcom.au • Email: info@gtg.com.au ABN 17 009 212 328
Registered Office and Main Laboratory • 60 Handver Street Fitzroy VIC 3065 Australia
Phone 61 3 9415 1136 • Fax 61 3 9417 2